Therefore, an exploratory study was undertaken to compare the response between subsequent use of anti-TNF agents and of bDMARDs with other MOAs in RA patients who have a history of anti-TNF treatment as their first bDMARD. This evidence concerns the gene TNF and rheumatoid arthritis.